Identification of differentially expressed genes in uveal melanoma using suppressive subtractive hybridization

Molecular Vision

Volumn 17, Issue , 2011, Pages 1324-1333

  Landreville, Solange ^a   Lupien, Caroline B ^a   Vigneault, Francois ^a   Gaudreault, Manon ^a   Mathieu, Mélissa ^a   Rousseau, Alain P ^a   Guérin, Sylvain L ^a   Salesse, Christian ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN GENE; ADULT; AGED; ANLN GENE; ANP32E GENE; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN TP31; CKAP5 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CTSK GENE; DNA MICROARRAY; DOWN REGULATION; DTL GENE; EDNRB GENE; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE ISOLATION; HUMAN; HUMAN CELL; MALE; MALIGNANT TRANSFORMATION; MELANOCYTE; MTAP GENE; NUCLEOTIDE SEQUENCE; PP3CA GENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; TSPYL5 GENE; TUMOR GENE; TYRP1 GENE; UNINDEXED SEQUENCE; UPREGULATION; UVEA MELANOMA; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; COMPARATIVE GENOMIC HYBRIDIZATION; DOWN-REGULATION; EYE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MELANOCYTES; MELANOMA; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; UVEAL NEOPLASMS;

EID: 79959281100     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Landreville S, Agapova OA, Harbour JW. Emerging insights into the molecular pathogenesis of uveal melanoma. Future Oncol 2008; 4:629-636. [PMID: 18922120]
2. Onken MD, Worley LA, Tuscan MD, Harbour JW. An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn 2010; 12:461-468. [PMID: 20413675]
3. Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM, Simpson EM, Barsh GS, Bastian BC. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009; 457:599-602. [PMID: 19078957]
4. Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O'Brien J, Bastian BC. Mutations in GNA11 in uveal melanoma. N Engl J Med 2010; 363:2191-2199. [PMID: 21083380]
5. Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010; 330:1410-1413. [PMID: 21051595]
6. Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C, Lal A, Wang CJ, Beaudry GA, Ciriello KM, Cook BP, Dufault MR, Ferguson AT, Gao Y, He TC, Hermeking H, Hiraldo SK, Hwang PM, Lopez MA, Luderer HF, Mathews B, Petroziello JM, Polyak K, Zawel L, Kinzler KW. Analysis of human transcriptomes. Nat Genet 1999; 23:387-388. [PMID: 10581018]
7. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 1996; 93:6025-6030. [PMID: 8650213]
8. Wan JS, Sharp SJ, Poirier GM, Wagaman PC, Chambers J, Pyati J, Hom YL, Galindo JE, Huvar A, Peterson PA, Jackson MR, Erlander MG. Cloning differentially expressed mRNAs. Nat Biotechnol 1996; 14:1685-1691. [PMID: 9634852]
9. Beliveau A, Berube M, Rousseau A, Pelletier G, Guerin SL. Expression of integrin alpha5beta1 and MMPs associated with epithelioid morphology and malignancy of uveal melanoma. Invest Ophthalmol Vis Sci 2000; 41:2363-2372. [PMID: 10892885]
10. Hu DN, McCormick SA, Ritch R, Pelton-Henrion K. Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes. Invest Ophthalmol Vis Sci 1993; 34:2210-2219. [PMID: 8505203]
11. McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 1983; 96:502-509. [PMID: 6624832]
12. Landreville S, Vigneault F, Bergeron M, Leclerc S, Gaudreault M, Morcos M, Mouriaux F, Salesse C, Guérin SL. Suppression of 5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines. Pigment Cell Melanoma Res 2011.
13. Proulx S, Landreville S, Guerin SL, Salesse C. Integrin alpha5 expression by the ARPE-19 cell line: comparison with primary RPE cultures and effect of growth medium on the alpha5 gene promoter strength. Exp Eye Res 2004; 79:157-165. [PMID: 15325562]
14. Zaniolo K, Desnoyers S, Leclerc S, Guerin SL. Regulation of poly(ADP-ribose) polymerase-1 (PARP-1) gene expression through the post-translational modification of Sp1: a nuclear target protein of PARP-1. BMC Mol Biol 2007; 8:96. [PMID: 17961220]
15. Piekny AJ, Maddox AS. The myriad roles of Anillin during cytokinesis. Semin Cell Dev Biol 2010; 21:881-891. [PMID: 20732437]
16. Hall PA, Todd CB, Hyland PL, McDade SS, Grabsch H, Dattani M, Hillan KJ, Russell SE. The septin-binding protein anillin is overexpressed in diverse human tumors. Clin Cancer Res 2005; 11:6780-6786. [PMID: 16203764]
17. Rusnak F, Mertz P. Calcineurin: form and function. Physiol Rev 2000; 80:1483-1521. [PMID: 11015619]
18. Buchholz M, Ellenrieder V. An emerging role for Ca2+/calcineurin/NFAT signaling in cancerogenesis. Cell Cycle 2007; 6:16-19. [PMID: 17245111]
19. Reuter A, Mi J, Sehrsam I, Ludolph AC, Volkel H. A novel calcineurin splice variant that modifies calcineurin activity. Eur J Biochem 2001; 268:5955-5960. [PMID: 11722584]
20. Bolander A, Agnarsdóttir M, Strömberg S, Ponten F, Hesselius P, Uhlen M, Bergqvist M. The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas. Cancer Genomics Proteomics 2008; 5:293-300. [PMID: 19287070]
21. Smith SL, Damato BE, Scholes AG, Nunn J, Field JK, Heighway J. Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival. Br J Cancer 2002; 87:1308-1313. [PMID: 12439722]
22. Meyer S, Wild PJ, Vogt T, Bataille F, Ehret C, Gantner S, Landthaler M, Klinkhammer-Schalke M, Hofstaedter F, Bosserhoff AK. Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma. Exp Dermatol 2010; 19:e251-e257. [PMID: 20500769]
23. Jafarnejad SM, Wani AA, Martinka M, Li G. Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion. Am J Pathol 2010; 177:2741-2752. [PMID: 20952589]
24. Walker TM, Van Ginkel PR, Gee RL, Ahmadi H, Subramanian L, Ksander BR, Meisner LF, Albert DM, Polans AS. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Arch Ophthalmol 2002; 120:1719-1725. [PMID: 12470148]
25. van Ginkel PR, Gee RL, Shearer RL, Subramanian L, Walker TM, Albert DM, Meisner LF, Varnum BC, Polans AS. Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Res 2004; 64:128-134. [PMID: 14729616]